RESONIUM CALCIUM

Google image searchProduct monograph

Active ingredient

calcium polystyrene sulfonate, 999 MG/G

DIN: 02017741

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: ORAL, RECTAL

Schedule: Ethical

Company: SANOFI-AVENTIS CANADA INC

Date: 18-JUL-2008

ATC:

• V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
• V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
• V03AE — Drugs for treatment of hyperkalemia and hyperphosphatemia (ATC, ATC/DDD)
• V03AE01 — POLYSTYRENE SULPHONATE (ATC/DDD)

Reference brand drug: Kayexalate

External Links for Resonium Calcium

Search on Google

• Resonium Calcium side effects
• Resonium Calcium dosage
• calcium polystyrene sulfonate side effects
• calcium polystyrene sulfonate dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find resonium calcium photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.